X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (94) 94
index medicus (89) 89
female (73) 73
oncology (60) 60
middle aged (58) 58
risk factors (57) 57
aged (54) 54
article (45) 45
adult (42) 42
male (39) 39
cancer (34) 34
health aspects (32) 32
public, environmental & occupational health (32) 32
prospective studies (31) 31
cohort studies (29) 29
risk (27) 27
proportional hazards models (25) 25
research (24) 24
diet (22) 22
body mass index (21) 21
breast-cancer (20) 20
epidemiology (20) 20
nutrition & dietetics (20) 20
united-states (20) 20
women (20) 20
obesity (19) 19
postmenopausal women (18) 18
physical-activity (17) 17
abridged index medicus (16) 16
aged, 80 and over (16) 16
mortality (16) 16
breast cancer (15) 15
medicin och hälsovetenskap (15) 15
iowa - epidemiology (14) 14
medical and health sciences (14) 14
physiological aspects (14) 14
health (13) 13
metaanalysis (13) 13
prevention (13) 13
surveys and questionnaires (13) 13
vitamin d (13) 13
young adult (13) 13
adolescent (12) 12
colorectal-cancer (12) 12
food frequency questionnaire (12) 12
pancreatic cancer (12) 12
smoking (12) 12
cohort (11) 11
consumption (11) 11
hematology (11) 11
survivors (11) 11
womens health (11) 11
association (10) 10
body-mass index (10) 10
exercise (10) 10
feeding behavior (10) 10
risk assessment (10) 10
cancer och onkologi (9) 9
clinical medicine (9) 9
dietary supplements (9) 9
follow-up studies (9) 9
klinisk medicin (9) 9
nutrition (9) 9
postmenopause (9) 9
women's health (9) 9
cancer and oncology (8) 8
confidence intervals (8) 8
diagnosis (8) 8
folic acid (8) 8
incidence (8) 8
oncology, experimental (8) 8
ovarian cancer (8) 8
public health (8) 8
quality of life (8) 8
tea (8) 8
analysis (7) 7
breast neoplasms - epidemiology (7) 7
cancer survivors (7) 7
care and treatment (7) 7
case-control studies (7) 7
coffee (7) 7
folate (7) 7
health risk assessment (7) 7
internal medicine (7) 7
multivariate analysis (7) 7
neoplasms - prevention & control (7) 7
older women (7) 7
ovarian neoplasms - epidemiology (7) 7
pooled analysis (7) 7
regression analysis (7) 7
united states (7) 7
united states - epidemiology (7) 7
waist circumference (7) 7
25-hydroxyvitamin d (6) 6
animals (6) 6
base-line characteristics (6) 6
colorectal cancer (6) 6
food (6) 6
genotype (6) 6
life style (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 07/2013, Volume 31, Issue 20, pp. 2607 - 2618
Journal Article
The Journal of Nutrition, ISSN 0022-3166, 04/2017, Volume 147, Issue 4, p. 538
Background: Leukocyte telomere length (LTL) is a biomarker of the aging process and is associated with the risk of chronic disease. Higher exposure to cadmium... 
Telomeres | Cadmium | Carotenoids | Physiological aspects | Leukocytes | Biological markers | Health aspects | Folic acid
Journal Article
Cancer, ISSN 0008-543X, 09/2017, Volume 123, Issue 17, pp. 3326 - 3334
BACKGROUND Survival after the diagnosis of diffuse large B‐cell lymphoma (DLBCL) has been increasing since 2002 because of improved therapies; however,... 
causes of death | standardized mortality ratio | rituximab with cyclophosphamide, doxorubicin, vincristine, and prednisone (R‐CHOP) | noncancer causes of death | cure | diffuse large B‐cell lymphoma | Surveillance, Epidemiology, and End Results (SEER) | cancer‐specific survival | cancer-specific survival | diffuse large B-cell lymphoma | rituximab with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) | UNITED-STATES | vincristine | EVENT-FREE SURVIVAL | PHASE-II | RISK | and End Results (SEER) | CHOP CHEMOTHERAPY | Epidemiology | CHEMOTHERAPY PLUS RITUXIMAB | rituximab with cyclophosphamide | TRIAL | THERAPY | Surveillance | ONCOLOGY | NON-HODGKIN-LYMPHOMA | doxorubicin | and prednisone (R-CHOP) | ELDERLY-PATIENTS | Predictive Value of Tests | Immunotherapy - methods | Age Factors | United States | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Cause of Death | Neoplasm Invasiveness - pathology | Aged, 80 and over | Adult | Female | Retrospective Studies | Databases, Factual | SEER Program | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Risk Assessment | Proportional Hazards Models | Combined Modality Therapy | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Sex Factors | Survival Analysis | Aged | Neoplasm Staging | Cancer patients | Chemotherapy | Usage | Lymphocytic leukemia | Diagnosis | Health aspects | Cancer | Cell survival | Gastrointestinal tract diseases | Risk groups | Mortality | Medical services | Patients | Survival | Lymphoma | Risk factors | Diseases | Extrapolation | Demographics | Vascular diseases | Lymphocytes B | Mathematical analysis | Risk assessment | Fatalities | Lymphomas | Health risk assessment | B-cell lymphoma
Journal Article
PLoS Medicine, ISSN 1549-1277, 2014, Volume 11, Issue 7, p. e1001673
Journal Article
Environment International, ISSN 0160-4120, 05/2019, Volume 126, pp. 242 - 251
Journal Article